Optimization and performance evaluation of peptide-loaded monolithic poly-ε-caprolactone microspheres in mice bearing melanoma B16F1

B. Denish Shenoy, M. Venkatesh, N. Udupa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The objective of this investigation was to develop a bleomycin depot based on monolithic microparticulate technology to suppress tumour growth and to maintain constant plasma drag concentrations within an optimal therapeutic window over a prolonged period of time. Formulations were optimized with biodegradable poly-ε-carpolactone and evaluated in vitro for physicochemical characteristics, drug release in phosphate buffered saline (pH 7.4) and evaluated in vivo in tumour beating mice. This investigation revealed that upon subcutaneous injection, the biodegradable depot-forming poly-ε-carpolactone microspheres controlled drag release and suppressed tumour growth kinetics significantly compared to control. A preliminary pharmacokinetic evaluation exhibited steady plasma drag concentrations during the study period. This formulation with its reduced frequency of administration and better control of drag disposition is expected to provide an economic benefit to the user compared with products currently available for chemotherapy.

Original languageEnglish
Pages (from-to)256-260
Number of pages5
JournalPharmazie
Volume57
Issue number4
Publication statusPublished - 2002

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Drug Discovery
  • Organic Chemistry
  • Chemistry(all)
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science

Cite this